SARS-CoV-2 rapid antigen detection tests – Authors' reply

[1]  R. Peeling,et al.  Scaling up COVID-19 rapid antigen tests: promises and challenges , 2021, The Lancet Infectious Diseases.

[2]  R. Walensky,et al.  SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. , 2021, JAMA.

[3]  Vineet D. Menachery,et al.  Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.

[4]  E. Albert,et al.  Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients , 2021, Clinical Microbiology and Infection.

[5]  Sergei L. Kosakovsky Pond,et al.  Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa , 2020, medRxiv.

[6]  D. Larremore,et al.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening , 2020, Science Advances.

[7]  M. Cevik,et al.  SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis , 2020, The Lancet Microbe.

[8]  E. Albert,et al.  Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres , 2020, Clinical Microbiology and Infection.

[9]  Vineet D. Menachery,et al.  Spike mutation D614G alters SARS-CoV-2 fitness , 2020, Nature.

[10]  S. Alexandersen,et al.  SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication , 2020, Nature Communications.

[11]  C. Kadelka,et al.  A model-based evaluation of the efficacy of COVID-19 social distancing, testing and hospital triage policies , 2020, medRxiv.